| scholarly article | Q13442814 |
| P50 | author | Bernard Crespi | Q14941842 |
| Steve Dorus | Q89463042 | ||
| P2093 | author name string | Kyle Summers | |
| P2860 | cites work | AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance | Q21092500 |
| Localizing recent adaptive evolution in the human genome | Q21145227 | ||
| A map of recent positive selection in the human genome | Q21563624 | ||
| An RNA gene expressed during cortical development evolved rapidly in humans | Q22122233 | ||
| Molecular evolution of FOXP2, a gene involved in speech and language | Q22122513 | ||
| Microcephalin, a Gene Regulating Brain Size, Continues to Evolve Adaptively in Humans | Q22337066 | ||
| Molecular evolution of microcephalin, a gene determining human brain size | Q22337145 | ||
| Reconstructing the evolutionary history of microcephalin, a gene controlling human brain size | Q22337146 | ||
| DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation | Q24305439 | ||
| LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia | Q24324059 | ||
| The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus | Q24533481 | ||
| Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia | Q24562939 | ||
| Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia | Q24670103 | ||
| The PANTHER database of protein families, subfamilies, functions and pathways | Q24795605 | ||
| Molecular heterosis: a review | Q26810050 | ||
| PAML: a program package for phylogenetic analysis by maximum likelihood | Q27861096 | ||
| Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia | Q28236058 | ||
| Molecular genetic studies of schizophrenia | Q28242041 | ||
| AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia | Q28245905 | ||
| The genetics and biology of DISC1--an emerging role in psychosis and cognition | Q28252172 | ||
| Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia | Q28263630 | ||
| The NPAS3 gene--emerging evidence for a role in psychiatric illness | Q28265950 | ||
| Replication of genetic association studies between markers at the Epsin 4 gene locus and schizophrenia in two Han Chinese samples | Q28270772 | ||
| A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms | Q28270982 | ||
| A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia | Q28276196 | ||
| Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome | Q28278080 | ||
| Family-based association study of Epsin 4 and Schizophrenia | Q28290620 | ||
| Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level | Q29547731 | ||
| Positive natural selection in the human lineage | Q29614585 | ||
| Natural selection on protein-coding genes in the human genome | Q29615352 | ||
| Accelerated evolution of nervous system genes in the origin of Homo sapiens | Q29618491 | ||
| Psychosis: a costly by-product of social brain evolution in Homo sapiens. | Q30353231 | ||
| Schizophrenia: the illness that made us human | Q30431179 | ||
| Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene | Q33285476 | ||
| Widespread positive selection in synonymous sites of mammalian genes | Q33285587 | ||
| Evidence for positive selection and population structure at the human MAO-A gene | Q33894576 | ||
| Evidence of positive selection acting at the human dopamine receptor D4 gene locus | Q33897512 | ||
| Contrasting effects of natural selection on human and chimpanzee CC chemokine receptor 5 | Q33938551 | ||
| Accelerated protein evolution and origins of human-specific features: Foxp2 as an example | Q33963696 | ||
| Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations. | Q33994158 | ||
| A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. | Q34075062 | ||
| Schizophrenia and HLA: a review | Q34133109 | ||
| Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population | Q80022949 | ||
| Association between the CCR5 32-bp deletion allele and late onset of schizophrenia | Q82714513 | ||
| Meta-analysis of association between ApoE epsilon4 allele and schizophrenia | Q82981983 | ||
| Schizophrenia and cancer risk: can the CCR5-delta 32 chemokine receptor gene mutation play a role? | Q83212805 | ||
| Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism | Q34144158 | ||
| Population-based association analyses of the HOPA12bp polymorphism for schizophrenia and hypothyroidism | Q34292812 | ||
| Schizophrenia-an evolutionary enigma? | Q34307794 | ||
| Schizophrenia as one extreme of a sexually selected fitness indicator | Q34332457 | ||
| Accelerated evolution of the pituitary adenylate cyclase-activating polypeptide precursor gene during human origin | Q34575442 | ||
| Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. | Q34578123 | ||
| Accelerated evolution of conserved noncoding sequences in humans | Q34578926 | ||
| Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? | Q34580529 | ||
| Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. | Q35089415 | ||
| Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia | Q35221473 | ||
| Meat-adaptive genes and the evolution of slower aging in humans | Q35752606 | ||
| Phenotype of schizophrenia: a review and formulation | Q35875976 | ||
| "A gene for...": the nature of gene action in psychiatric disorders | Q36182565 | ||
| Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? | Q36258629 | ||
| The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia | Q36376582 | ||
| Genomic insights into positive selection | Q36523414 | ||
| Role of DISC1 in neural development and schizophrenia | Q36720430 | ||
| Positive selection in MAOA gene is human exclusive: determination of the putative amino acid change selected in the human lineage | Q42635050 | ||
| A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population | Q43670595 | ||
| Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. | Q44132357 | ||
| Serotonin transporter gene polymorphism and schizoid personality traits in the patients with psychosis and psychiatrically well subjects | Q44312615 | ||
| Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses | Q44369831 | ||
| Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families | Q44894348 | ||
| Polymorphisms in the serotonin transporter and monoamine oxidase A genes and their relationship to personality traits measured by the Temperament and Character Inventory and NEO Five-Factor Inventory in healthy volunteers | Q45006282 | ||
| Evidence for a common biological basis of the Absorption trait, hallucinogen effects, and positive symptoms: epistasis between 5-HT2a and COMT polymorphisms | Q46555897 | ||
| Identification of first candidate genes for creativity: a pilot study | Q46887424 | ||
| The geographic distribution of monoamine oxidase haplotypes supports a bottleneck during the dispersion of modern humans from Africa | Q46932739 | ||
| Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population | Q47399632 | ||
| Association of the HOPA12bp allele with a large X-chromosome haplotype and positive symptom schizophrenia | Q47702365 | ||
| Recent origin of HLA-DRB1 alleles and implications for human evolution | Q47768279 | ||
| Genome-wide linkage scan of schizophrenia: a cross-isolate study. | Q47829678 | ||
| Schizophrenia as a consequence of brain evolution | Q48486531 | ||
| Is schizophrenia the price that Homo sapiens pays for language? | Q48532706 | ||
| The association of the HOPA(12bp) polymorphism with schizophrenia in the NIMH Genetics Initiative for Schizophrenia sample. | Q51906900 | ||
| Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. | Q51915251 | ||
| Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands. | Q51946378 | ||
| Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. | Q51975730 | ||
| Recent divergence of the HLA-DRB1*04 allelic lineage from the DRB1*0701 lineage after the separation of the human and chimpanzee species. | Q52842406 | ||
| Selective sweeps in the human genome: a starting point for identifying genetic differences between modern humans and chimpanzees. | Q52842542 | ||
| GABRB2 Association with Schizophrenia: Commonalities and Differences Between Ethnic Groups and Clinical Subtypes | Q57258788 | ||
| Extreme individual marker FST values do not imply population-specific selection in humans: the NRG1 example | Q57305140 | ||
| Schizotypal dimensions in normals and schizophrenic patients: a comparison with other clinical samples | Q60646646 | ||
| P433 | issue | 1627 | |
| P921 | main subject | schizophrenia | Q41112 |
| adaptive evolution | Q113049937 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 2801-2810 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Proceedings of the Royal Society B | Q2625424 |
| P1476 | title | Adaptive evolution of genes underlying schizophrenia | |
| P478 | volume | 274 |
| Q36835294 | 'Finitics'. A plea for biological realism |
| Q46245691 | A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia |
| Q28655504 | A dual comparative approach: integrating lines of evidence from human evolutionary neuroanatomy and neurodevelopmental disorders |
| Q93065173 | A method for genome-wide genealogy estimation for thousands of samples |
| Q33539809 | A recombination hotspot in a schizophrenia-associated region of GABRB2 |
| Q37607938 | Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. |
| Q46306295 | Ancestral resurrection of anthropoid estrogen receptor β demonstrates functional consequences of positive selection. |
| Q33746823 | Candidate gene associations with mood disorder, cognitive vulnerability, and fronto-limbic volumes. |
| Q90598616 | Commentary on: "Host-parasite interaction associated with major mental illness". Why we need integrative explanations based on evolutionary theory |
| Q34345299 | Creativity, psychosis and human evolution: The exemplar case of neuregulin 1 gene |
| Q42145626 | Decoding the molecular evolution of human cognition using comparative genomics |
| Q26782139 | Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology |
| Q37433965 | Disease consequences of human adaptation. |
| Q38846088 | Evidence of a Conserved Molecular Response to Selection for Increased Brain Size in Primates |
| Q28657468 | Evolutionary conservation in genes underlying human psychiatric disorders |
| Q30986287 | FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies |
| Q28593528 | From PPROM to caul: The evolution of membrane rupture in mammals. |
| Q30914210 | Genome-wide scan for signatures of human population differentiation and their relationship with natural selection, functional pathways and diseases |
| Q35533902 | Genomic and network patterns of schizophrenia genetic variation in human evolutionary accelerated regions |
| Q33382735 | Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum |
| Q35960747 | Genomic sister-disorders of neurodevelopment: an evolutionary approach |
| Q95579823 | How evolutionary psychiatry can advance psychopharmacology |
| Q28744614 | Human brain evolution: harnessing the genomics (r)evolution to link genes, cognition, and behavior |
| Q38259827 | Mitochondrial dysfunction in schizophrenia: an evolutionary perspective |
| Q26745243 | Molecular Signatures of Natural Selection for Polymorphic Genes of the Human Dopaminergic and Serotonergic Systems: A Review |
| Q34381421 | Nonhuman primate models in the genomic era: a paradigm shift. |
| Q36367450 | Paradox of schizophrenia genetics: is a paradigm shift occurring? |
| Q28259472 | Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease |
| Q39170724 | Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius |
| Q57132733 | Positive and balancing selection on gene associated with psychiatric disorders and human-unique personality traits |
| Q28285118 | Psychosis and autism as diametrical disorders of the social brain |
| Q43192078 | Psychosis endophenotypes in schizophrenia and bipolar disorder |
| Q55168713 | Recently evolved human-specific methylated regions are enriched in schizophrenia signals. |
| Q33707645 | Relating schizotypy and personality to the phenomenology of creativity |
| Q36288960 | Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. |
| Q21284097 | Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation |
| Q34786420 | Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. |
| Q35144224 | Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis |
| Q37011584 | Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework |
| Q36148471 | Systematic Integration of Brain eQTL and GWAS Identifies ZNF323 as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function |
| Q38259558 | The Duality of Schizotypy: Is it Both Dimensional and Categorical? |
| Q37730425 | The adaptive brain in mental health: overcoming inherited risk factors. |
| Q33809026 | The dystrobrevin-binding protein 1 gene: features and networks |
| Q36493625 | The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). |
| Q35960713 | The great opportunity: Evolutionary applications to medicine and public health |
| Q37791205 | The origins and evolution of genetic disease risk in modern humans |
| Q28756691 | The role of positive selection in determining the molecular cause of species differences in disease |
| Q36744352 | Using Evolutionary Theory to Guide Mental Health Research. |
Search more.